PAX8 as a Potential Target for Ovarian Cancer: What We Know so Far

被引：9

作者：

Di Palma, Tina ^{[1
]}

Zannini, Mariastella ^{[1
,2
]}

机构：

[1] CNR, Inst Expt Endocrinol & Oncol G Salvatore, IEOS, I-80131 Naples, Italy

[2] CNR, Inst Expt Endocrinol & Oncol G Salvatore, IEOS, via S Pansini 5, I-80131 Naples, Italy

来源：

ONCOTARGETS AND THERAPY | 2022年 / 15卷

关键词：

PAX8; ovarian cancer; transcription factor; Fallopian tube; STICs; PAIRED BOX GENE; DIAGNOSTIC UTILITY; FALLOPIAN-TUBE; USEFUL MARKER; RENAL TUMORS; EXPRESSION; PATHOGENESIS; CARCINOMAS; ORIGIN; DIFFERENTIATION;

D O I：

10.2147/OTT.S361511

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The Fallopian tube epithelium harbors the origin cells for the majority of high-grade serous ovarian carcinomas (HGSCs), the most lethal form of gynecologic malignancies. PAX8 belongs to the paired-box gene family of transcription factors and it is a marker of the FTE secretory cell lineage. Its role has been investigated in migration, invasion, proliferation, cell survival, stem cell maintenance, angiogenesis and tumor growth. In this review, we focus on the pro-tumorigenic role of PAX8 in ovarian cancer; in this context, PAX8 possibly continues to exert its transcriptional activity on its physiological targets but may also function on newly available targets after the tumorigenic hits. Acquiring new insights into the different PAX8 mechanism(s) of action in the tumor microenvironment could uncover new viable therapeutic targets and thus improve the current treatment regimen.

引用

页码：1273 / 1280

页数：8

共 78 条

[1] The PAX8 cistrome in epithelial ovarian cancer [J].

Adler, Emily K. ;

Corona, Rosario I. ;

Lee, Janet M. ;

Rodriguez-Malave, Norma ;

Mhawech-Fauceglia, Paulette ;

Sowter, Heidi ;

Hazelett, Dennis J. ;

Lawrenson, Kate ;

Gayther, Simon A. .

ONCOTARGET, 2017, 8 (65) :108316-108332

[2] PAX-8 expression in renal tumours and distant sites: A useful marker of primary and metastatic renal cell carcinoma? [J].

Barr, Meaghan L. ;

Jilaveanu, Lucia B. ;

Camp, Robert L. ;

Adeniran, Adebowale J. ;

Kluger, Harriet M. ;

Shuch, Brian .

JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (01) :12-17

[3] Defining the molecular evolution of extrauterine high grade serous carcinoma [J].

Beirne, James P. ;

McArt, Darragh G. ;

Roddy, Aideen ;

McDermott, Clara ;

Ferris, Jennifer ;

Buckley, Niamh E. ;

Coulter, Paula ;

McCabe, Nuala ;

Eddie, Sharon L. ;

Dunne, Philip D. ;

O'Reilly, Paul ;

Gilmore, Alan ;

Feeney, Laura ;

Ewing, David Lyons ;

Drapkin, Ronny, I ;

Salto-Tellez, Manuel ;

Kennedy, Richard D. ;

Harley, Ian J. G. ;

McCluggage, W. Glenn ;

Mullan, Paul B. .

GYNECOLOGIC ONCOLOGY, 2019, 155 (02) :305-317

[4] PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck [J].

Bishop, Justin A. ;

Sharma, Rajni ;

Westra, William H. .

HUMAN PATHOLOGY, 2011, 42 (12) :1873-1877

[5] PAX8 and MECOM are interaction partners driving ovarian cancer [J].

Bleu, Melusine ;

Mermet-Meillon, Fanny ;

Apfel, Verena ;

Barys, Louise ;

Holzer, Laura ;

Salvy, Marianne Bachmann ;

Lopes, Rui ;

Barbosa, Ines Amorim Monteiro ;

Delmas, Cecile ;

Hinniger, Alexandra ;

Chau, Suzanne ;

Kaufmann, Markus ;

Haenni, Simon ;

Berneiser, Karolin ;

Wahle, Maria ;

Moravec, Ivana ;

Vissieres, Alexandra ;

Poetsch, Tania ;

Ahrne, Erik ;

Carte, Nathalie ;

Voshol, Johannes ;

Bechter, Elisabeth ;

Hamon, Jacques ;

Meyerhofer, Marco ;

Erdmann, Dirk ;

Fischer, Matteo ;

Stachyra, Therese ;

Freuler, Felix ;

Gutmann, Sascha ;

Fernandez, Cesar ;

Schmelzle, Tobias ;

Naumann, Ulrike ;

Roma, Guglielmo ;

Lawrenson, Kate ;

Nieto-Oberhuber, Cristina ;

Cobos-Correa, Amanda ;

Ferretti, Stephane ;

Schuebeler, Dirk ;

Galli, Giorgio Giacomo .

NATURE COMMUNICATIONS, 2021, 12 (01)

[6] PAX8 activates metabolic genes via enhancer elements in Renal Cell Carcinoma [J].

Bleu, Melusine ;

Gaulis, Swann ;

Lopes, Rui ;

Sprouffske, Kathleen ;

Apfel, Verena ;

Holwerda, Sjoerd ;

Pregnolato, Marco ;

Yildiz, Umut ;

Cordo, Valentina ;

Dost, Antonella F. M. ;

Knehr, Judith ;

Carbone, Walter ;

Lohmann, Felix ;

Lin, Charles Y. ;

Bradner, James E. ;

Kauffmann, Audrey ;

Tordella, Luca ;

Roma, Guglielmo ;

Galli, Giorgio G. .

NATURE COMMUNICATIONS, 2019, 10 (1)

[7] Nephric lineage specification by Pax2 and Pax8 [J].

Bouchard, M ;

Souabni, A ;

Mandler, M ;

Neubüser, A ;

Busslinger, M .

GENES & DEVELOPMENT, 2002, 16 (22) :2958-2970

[8] Emerging roles for PAX8 in ovarian cancer and endosalpingeal development [J].

Bowen, Nathan J. ;

Logani, Sanjay ;

Dickerson, Erin B. ;

Kapa, Laura B. ;

Akhtar, Mariam ;

Benigno, Benedict B. ;

McDonald, John F. .

GYNECOLOGIC ONCOLOGY, 2007, 104 (02) :331-337

[9] Identification of Pax protein inhibitors that suppress target gene expression and cancer cell proliferation [J].

Bradford, Shayna T. J. ;

Grimley, Edward ;

Laszczyk, Ann M. ;

Lee, Pil H. ;

Patel, Sanjeevkumar R. ;

Dressler, Gregory R. .

CELL CHEMICAL BIOLOGY, 2022, 29 (03) :412-+

[10] PAX8 is a potential marker for the diagnosis of primary epithelial ovarian cancer [J].

Chai, Hong-Juan ;

Ren, Qing ;

Fan, Qin ;

Ye, Liu ;

Du, Guang-Ye ;

Du, Hua-Wen ;

Xu, Wei ;

Li, Yue ;

Zhang, Lan ;

Cheng, Zhong-Ping .

ONCOLOGY LETTERS, 2017, 14 (05) :5871-5875

← 1 2 3 4 5 6 7 8 →